Fenoxedil

This classification denotes a vasodilating agent with the molecular formula C28H42N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ABX8234H6M, chemically known as 2-(p-butoxyphenoxy)-n-(2,5-diethoxyphenyl)-n-(2-(diethylamino)ethyl)acetamide but generally known as fenoxedil, which bears US NIH Compound Identifier 71731. European Medicines Agency schedules Fenoxedil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07582MIG. The term FENOXEDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). FENOXEDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenoxedil under HS 29242995 and SITC 51479. As of Q4 2014, FENOXEDIL remains the US FDA Preferred Term for this commodity. Fenoxedil bears US NLM identifiers UMLS ID C0060184 and NCI Concept Code C65662. SMILES: O(c1c(N(CCN(CC)CC)C(=O)COc2ccc(OCCCC)cc2)cc(OCC)cc1)CC.